Roche hemophilia drug wins fast-track FDA designation
 

Roche hemophilia drug wins fast-track FDA designation
ZURICH (Reuters) - Roche said on Friday it had won breakthrough therapy designation from the U.S. Food and Drug Administration for an experimental hemophilia medicine, aiming for a piece of the $11 billion hemophilia drug market.
http://i2.wp.com/reuters.us.feedspor...f?resize=1%2C1http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...hc:F7zBnMyn0Lo http://feeds.feedburner.com/~ff/reut...hc:V_sGLiPBpWU
http://feeds.feedburner.com/~r/reute...~4/ExW_16IX6D8